Literature DB >> 19733152

The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites.

Elisa Greggio1, Jean-Marc Taymans, Eugene Yuejun Zhen, John Ryder, Renée Vancraenenbroeck, Alexandra Beilina, Peng Sun, Junpeng Deng, Howard Jaffe, Veerle Baekelandt, Kalpana Merchant, Mark R Cookson.   

Abstract

Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of inherited Parkinson's disease (PD). The protein is large and complex, but pathogenic mutations cluster in a region containing GTPase and kinase domains. LRRK2 can autophosphorylate in vitro within a dimer pair, although the significance of this reaction is unclear. Here, we mapped the sites of autophosphorylation within LRRK2 and found several potential phosphorylation sites within the GTPase domain. Using mass spectrometry, we found that Thr1343 is phosphorylated and, using kinase dead versions of LRRK2, show that this is an autophosphorylation site. However, we also find evidence for additional sites in the GTPase domain and in other regions of the protein suggesting that there may be multiple autophosphorylation sites within LRRK2. These data suggest that the kinase and GTPase activities of LRRK2 may exhibit complex autoregulatory interdependence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733152      PMCID: PMC2759846          DOI: 10.1016/j.bbrc.2009.08.163

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

Review 1.  Autophosphorylation: a salient feature of protein kinases.

Authors:  J A Smith; S H Francis; J D Corbin
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

2.  LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain.

Authors:  Daniel Korr; Luisella Toschi; Peter Donner; Hans-Dieter Pohlenz; Bertolt Kreft; Bertram Weiss
Journal:  Cell Signal       Date:  2005-10-21       Impact factor: 4.315

3.  Characterization of lentiviral vector-mediated gene transfer in adult mouse brain.

Authors:  Veerle Baekelandt; Anje Claeys; Kristel Eggermont; Erwin Lauwers; Bart De Strooper; Bart Nuttin; Zeger Debyser
Journal:  Hum Gene Ther       Date:  2002-05-01       Impact factor: 5.695

4.  Investigation of leucine-rich repeat kinase 2 : enzymological properties and novel assays.

Authors:  Vasanti S Anand; Laurie J Reichling; Kerri Lipinski; Wayne Stochaj; Weili Duan; Kerry Kelleher; Pooja Pungaliya; Eugene L Brown; Peter H Reinhart; Richard Somberg; Warren D Hirst; Steven M Riddle; Steven P Braithwaite
Journal:  FEBS J       Date:  2009-01       Impact factor: 5.542

5.  Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications.

Authors:  Hong Qing; Winnie Wong; Edith G McGeer; Patrick L McGeer
Journal:  Biochem Biophys Res Commun       Date:  2009-07-01       Impact factor: 3.575

6.  Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.

Authors:  Yuzuru Imai; Stephan Gehrke; Hua-Qin Wang; Ryosuke Takahashi; Kazuko Hasegawa; Etsuro Oota; Bingwei Lu
Journal:  EMBO J       Date:  2008-08-14       Impact factor: 11.598

7.  Leucine-rich repeat kinase 2 mutants I2020T and G2019S exhibit altered kinase inhibitor sensitivity.

Authors:  Laurie J Reichling; Steven M Riddle
Journal:  Biochem Biophys Res Commun       Date:  2009-05-03       Impact factor: 3.575

8.  LRRK2 gene variation and its contribution to Parkinson disease.

Authors:  Coro Paisán-Ruiz
Journal:  Hum Mutat       Date:  2009-08       Impact factor: 4.878

9.  The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro.

Authors:  Christian Johannes Gloeckner; Annette Schumacher; Karsten Boldt; Marius Ueffing
Journal:  J Neurochem       Date:  2009-03-03       Impact factor: 5.372

Review 10.  Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.

Authors:  Elisa Greggio; Mark R Cookson
Journal:  ASN Neuro       Date:  2009-04-14       Impact factor: 4.146

View more
  73 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

2.  Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.

Authors:  Veronique Daniëls; Renée Vancraenenbroeck; Bernard M H Law; Elisa Greggio; Evy Lobbestael; Fangye Gao; Marc De Maeyer; Mark R Cookson; Kirsten Harvey; Veerle Baekelandt; Jean-Marc Taymans
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

3.  Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice.

Authors:  M Yue; K M Hinkle; P Davies; E Trushina; F C Fiesel; T A Christenson; A S Schroeder; L Zhang; E Bowles; B Behrouz; S J Lincoln; J E Beevers; A J Milnerwood; A Kurti; P J McLean; J D Fryer; W Springer; D W Dickson; M J Farrer; H L Melrose
Journal:  Neurobiol Dis       Date:  2015-03-31       Impact factor: 5.996

Review 4.  Role of LRRK2 kinase dysfunction in Parkinson disease.

Authors:  Azad Kumar; Mark R Cookson
Journal:  Expert Rev Mol Med       Date:  2011-06-13       Impact factor: 5.600

Review 5.  Mechanisms of LRRK2-mediated neurodegeneration.

Authors:  Elpida Tsika; Darren J Moore
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

6.  Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities.

Authors:  Philip J Webber; Archer D Smith; Saurabh Sen; Matthew B Renfrow; James A Mobley; Andrew B West
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

7.  Down-regulation of LRRK2 in control and DAT transfected HEK cells increases manganese-induced oxidative stress and cell toxicity.

Authors:  Jerome A Roth; Michelle Eichhorn
Journal:  Neurotoxicology       Date:  2013-04-27       Impact factor: 4.294

8.  ARHGEF7 (Beta-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2.

Authors:  Karina Haebig; Christian Johannes Gloeckner; Marta Garcia Miralles; Frank Gillardon; Claudia Schulte; Olaf Riess; Marius Ueffing; Saskia Biskup; Michael Bonin
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

9.  14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.

Authors:  R Jeremy Nichols; Nicolas Dzamko; Nicholas A Morrice; David G Campbell; Maria Deak; Alban Ordureau; Thomas Macartney; Youren Tong; Jie Shen; Alan R Prescott; Dario R Alessi
Journal:  Biochem J       Date:  2010-09-15       Impact factor: 3.857

10.  The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation.

Authors:  Azad Kumar; Elisa Greggio; Alexandra Beilina; Alice Kaganovich; Diane Chan; Jean-Marc Taymans; Benjamin Wolozin; Mark R Cookson
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.